Table of Contents
Jefferies Global Healthcare Conference in London
Date: November 17-20, 2025
To view the webcast, please click here.
Jefferies Global Healthcare Conference in London
Related
3T Biosciences Announces Appointments of Behzad Kharabi, M.D., as Chief Medical Officer, and Parker Institute for Cancer Immunotherapy (PICI) CEO Karen Knudsen, MBA, Ph.D., to Board of Directors
✨ Onyx Summary 3T Biosciences appointed Behzad Kharabi, M.D., as chief medical officer and Parker Institute for Cancer Immunotherapy CEO Karen E. Knudsen, Ph.D., MBA, to its board of directors as it advances its bispecific T-cell engager pipeline for solid tumors. The additions strengthen the company’s clinical development
ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of the “100 Most Influential People in Oncology in 2025”
✨ Onyx Summary ImmunityBio announced that OncoDaily has named its founder and executive chairman, Patrick Soon-Shiong, to The 100 Most Influential People in Oncology in 2025. The recognition underscores Soon-Shiong’s long-standing impact on oncology research and leadership, reinforcing ImmunityBio’s scientific credibility and visibility within the global cancer research and
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
✨ Onyx Summary Guardant Health said it will present and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12. The presentation provides the company with exposure to a major healthcare investment audience through a live and archived webcast
enGene Reports Full Year 2025 Financial Results and Provides Business Update
✨ Onyx Summary enGene Holdings Inc. reported full-year 2025 financial results and a business update, highlighting completion of enrollment in the pivotal LEGEND cohort for detalimogene in BCG-unresponsive NMIBC and a cash position of $342.4 million, extending operating runway into the second half of 2028. The company outlined plans to